(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 29.83%12.69B | 45.91%8.73B | 47.82%2.81B | 26.19%16.15B | 33.88%9.77B | 40.06%5.98B | 68.27%1.9B | 9.63%12.8B | 6.66%7.3B | -9.46%4.27B |
Operating income | 29.83%12.69B | 45.91%8.73B | 47.82%2.81B | 26.19%16.15B | 33.88%9.77B | 40.06%5.98B | 68.27%1.9B | 9.63%12.8B | 6.66%7.3B | -9.46%4.27B |
Operating expenses | -26.61%-11.58B | -43.20%-8.08B | -41.42%-2.55B | -26.51%-15.08B | -34.30%-9.15B | -41.85%-5.64B | -75.86%-1.8B | -13.74%-11.92B | -9.81%-6.81B | 10.12%-3.98B |
Gross profit | 77.06%1.1B | 90.86%648.72M | 168.45%256.86M | 21.86%1.07B | 27.94%622.78M | 15.78%339.89M | -7.17%95.68M | -26.47%878.22M | -23.88%486.77M | 0.49%293.55M |
Selling expenses | -96.31%-39.73M | -1.81%-12.91M | -255.71%-26.5M | -10.06%-119.71M | 75.71%-20.24M | 66.74%-12.68M | 56.41%-7.45M | 17.58%-108.77M | 23.85%-83.32M | -8.86%-38.11M |
Administrative expenses | 4.78%-424.01M | -6.13%-290.62M | -9.43%-134.38M | -21.12%-663.3M | -16.74%-445.3M | -11.55%-273.84M | -7.07%-122.81M | -13.17%-547.62M | -23.82%-381.44M | -17.32%-245.49M |
Research and development expenses | -67.49%-694.51M | -82.78%-423.01M | -125.18%-136.98M | -14.28%-658.53M | -16.28%-414.66M | -4.68%-231.43M | 35.31%-60.83M | 6.68%-576.25M | 14.54%-356.59M | 10.02%-221.09M |
Profit from asset sales | -160.29%-28.47M | ---32.49M | ---- | 2,743.73%50.35M | 2,554.71%47.22M | ---- | ---- | -135.51%-1.9M | -134.73%-1.92M | ---- |
Revaluation surplus | 13.42%-87.78M | -50.01%-64.86M | -732.96%-27.01M | -339.43%-102.69M | -120.66%-101.38M | -349.39%-43.23M | -86.28%4.27M | -123.06%-23.37M | -180.19%-45.95M | -65.23%17.34M |
-Changes in the fair value of other assets | 13.42%-87.78M | -50.01%-64.86M | -732.96%-27.01M | -339.43%-102.69M | -120.66%-101.38M | -349.39%-43.23M | -86.28%4.27M | -123.06%-23.37M | -180.19%-45.95M | -65.23%17.34M |
Impairment and provision | -210.65%-11.24M | 66.32%-3.7M | 27.98%-5.98M | 97.26%-2.8M | 41.89%-3.62M | -524.06%-10.98M | -475.35%-8.31M | 24.68%-102.4M | 72.06%-6.23M | 87.79%-1.76M |
-Other impairment is provision | -210.65%-11.24M | 66.32%-3.7M | 27.98%-5.98M | 97.26%-2.8M | 41.89%-3.62M | -524.06%-10.98M | -475.35%-8.31M | 24.68%-102.4M | 72.06%-6.23M | 87.79%-1.76M |
Special items of operating profit | 223.10%227.2M | 595.59%180.96M | 322.49%20.43M | -76.65%174.67M | 59.74%70.32M | 905.59%26.01M | -55.09%4.83M | 399.55%747.9M | -45.63%44.02M | 117.44%2.59M |
Operating profit | 109.03%23.29M | 95.64%-9.36M | 40.62%-57.27M | -213.55%-278.69M | 28.36%-257.91M | -5.49%-214.75M | -19.01%-96.45M | 286.97%245.43M | -340.75%-360.01M | -11.03%-203.57M |
Financing cost | -36.81%177.44M | -29.83%159.76M | 147.15%84.19M | -22.38%348.85M | -31.05%280.79M | -1.28%227.65M | -17.38%34.06M | 1,003.24%449.42M | 768.59%407.21M | 875.77%230.6M |
Special items of earning before tax | -61.42%815.33K | -38.05%326.52K | -76.41%57.54K | -44.69%2.93M | 76.95%2.11M | -59.57%527.1K | -21.01%243.92K | -51.77%5.3M | -67.53%1.19M | -41.98%1.3M |
Earning before tax | 706.17%201.55M | 1,021.80%150.72M | 143.41%26.98M | -89.56%73.09M | -48.34%25M | -52.59%13.44M | -57.29%-62.14M | 508.04%700.15M | 255.50%48.39M | 118.00%28.34M |
Tax | 431.49%48.68M | 610.76%33.91M | -122.98%-2.3M | -98.87%113.63K | 168.24%9.16M | 4,669.95%4.77M | 34.43%9.99M | 191.61%10.04M | -219.24%-13.42M | -98.39%100.01K |
After-tax profit from continuing operations | 632.52%250.23M | 914.10%184.63M | 147.32%24.68M | -89.69%73.21M | -2.32%34.16M | -35.98%18.21M | -62.59%-52.15M | 581.63%710.19M | 276.05%34.97M | 118.80%28.44M |
Earning after tax | 632.52%250.23M | 914.10%184.63M | 147.32%24.68M | -89.69%73.21M | -2.32%34.16M | -35.98%18.21M | -62.59%-52.15M | 581.63%710.19M | 276.05%34.97M | 118.80%28.44M |
Minority profit | 532.15%62.97M | 581.88%37.78M | 136.52%9.31M | 15.71%25.14M | -11.29%9.96M | -41.74%5.54M | -29.00%-25.48M | -12.40%21.73M | 143.25%11.23M | 116.92%9.51M |
Profit attributable to shareholders | 673.83%187.26M | 1,059.43%146.85M | 157.65%15.37M | -93.02%48.07M | 1.92%24.2M | -33.09%12.67M | -116.46%-26.67M | 767.22%688.46M | 289.25%23.74M | 119.92%18.93M |
Basic earnings per share | 674.85%0.1325 | 1,054.44%0.1039 | 157.67%0.0109 | -93.02%0.034 | 1.79%0.0171 | -32.84%0.009 | -117.24%-0.0189 | 766.73%0.4871 | 290.70%0.0168 | 119.94%0.0134 |
Diluted earnings per share | 674.85%0.1325 | 1,054.44%0.1039 | 157.67%0.0109 | -93.02%0.034 | 1.79%0.0171 | -32.84%0.009 | -117.24%-0.0189 | 766.73%0.4871 | 290.70%0.0168 | 119.94%0.0134 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data